Dermata therapeutics inc DRMA.US Value Analysis
US StockHealth Care
(No presentation for DRMA)
DRMA Value Score
3
24
15
Poor Growth
- AI analysis rates DRMA with the lowest value score of 1.
- It is mainly due to unstable operating cash flow, along with potential value may be lower.
- Over the past 3 months, DRMA has maintained a consecutive value rating of 1.0, slightly higher than the rating of 0.2 over the past 3 years. However, growth opportunities for enterprise value remain relatively low.
- Compared to all stocks in the Health Care sector, DRMA has a lower value rating.
DRMA Value Reference Factors
The Value score is derived from various data and factor information, integrated through AI algorithms. The following factors are part of the evaluation used by AI value scores.
No related data records
DRMA Financial Forecast
Unit : USD
Update to 2025/5/9 (Quarterly Update)
DRMA Earnings Table
No related data records
DRMA Historical Value Score
You can use historical scores of 3 or above to observe potential performance and make investment decisions.
DRMA Value Strategy Backtest
The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.
Entry
Exit
The Backtest Result of DRMA from 2021/08 till Now
- -
- Cumulative Return
- -
- Annual Return
- -
- Volatility
- -
- Sharpe Ratio
Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from August, 2021 to May, 2025. (Total Trades: 0)
| DRMA | Sector | US Overall Market | |
|---|---|---|---|
| Wining Rate | - | 44% | 54% |
| Avg Return | - | 63.5% | 72.8% |
| Avg Profit | - | 198.7% | 166% |
| Avg Loss | - | -44.7% | -34.6% |
| Avg Risk-Reward Ratio | - | 444.3% | 479.7% |
Update to 2025/5/9 (Daily Update)